Wellington Management Group’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$662K Sell
20,993
-1,231
-6% -$38.8K ﹤0.01% 1763
2025
Q1
$728K Sell
22,224
-1,276
-5% -$41.8K ﹤0.01% 1766
2024
Q4
$850K Sell
23,500
-2,826
-11% -$102K ﹤0.01% 1728
2024
Q3
$821K Sell
26,326
-14,350
-35% -$447K ﹤0.01% 1728
2024
Q2
$1.09M Buy
40,676
+2,958
+8% +$79.1K ﹤0.01% 1646
2024
Q1
$1.29M Sell
37,718
-14,611
-28% -$498K ﹤0.01% 1623
2023
Q4
$1.51M Buy
+52,329
New +$1.51M ﹤0.01% 1541
2021
Q1
Sell
-12,598
Closed -$317K 2180
2020
Q4
$317K Sell
12,598
-3,366
-21% -$84.7K ﹤0.01% 1807
2020
Q3
$332K Sell
15,964
-31,674
-66% -$659K ﹤0.01% 1795
2020
Q2
$1.13M Buy
47,638
+19,270
+68% +$458K ﹤0.01% 1468
2020
Q1
$510K Buy
+28,368
New +$510K ﹤0.01% 1692
2019
Q2
Sell
-19,520
Closed -$684K 2123
2019
Q1
$684K Buy
+19,520
New +$684K ﹤0.01% 1847
2018
Q3
Sell
-54,288
Closed -$3.25M 2306
2018
Q2
$3.25M Sell
54,288
-134,666
-71% -$8.06M ﹤0.01% 1612
2018
Q1
$8.65M Sell
188,954
-43,351
-19% -$1.99M ﹤0.01% 1324
2017
Q4
$9.26M Sell
232,305
-10,695
-4% -$426K ﹤0.01% 1291
2017
Q3
$9.72M Sell
243,000
-5,488
-2% -$220K ﹤0.01% 1272
2017
Q2
$10.7M Buy
248,488
+22,583
+10% +$973K ﹤0.01% 1198
2017
Q1
$7.07M Buy
225,905
+31,945
+16% +$1,000K ﹤0.01% 1333
2016
Q4
$4.9M Sell
193,960
-201,653
-51% -$5.09M ﹤0.01% 1406
2016
Q3
$9.78M Buy
395,613
+178,881
+83% +$4.42M ﹤0.01% 1188
2016
Q2
$4.42M Buy
216,732
+69,611
+47% +$1.42M ﹤0.01% 1378
2016
Q1
$2.24M Sell
147,121
-87,669
-37% -$1.34M ﹤0.01% 1565
2015
Q4
$3.16M Buy
234,790
+136,249
+138% +$1.83M ﹤0.01% 1492
2015
Q3
$1.38M Buy
98,541
+72,336
+276% +$1.01M ﹤0.01% 1747
2015
Q2
$445K Buy
+26,205
New +$445K ﹤0.01% 1976
2014
Q1
Sell
-70,700
Closed -$533K 2223
2013
Q4
$533K Sell
70,700
-1,800
-2% -$13.6K ﹤0.01% 1969
2013
Q3
$531K Sell
72,500
-70,200
-49% -$514K ﹤0.01% 1946
2013
Q2
$917K Buy
+142,700
New +$917K ﹤0.01% 1784